Insider Transactions in Q3 2020 at Turning Point Therapeutics, Inc. (TPTX)

TPTX Quotes by TradingView

Insider Transaction List (Q3 2020)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Jul 13 2020
Andrew John Partridge EVP & Chief Commercial Officer
BUY
Grant, award, or other acquisition
Direct
21,500 +50.0%
-

Track Institutional and Insider Activities on TPTX

Follow Turning Point Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TPTX shares.

Notify only if

Insider Trading

Get notified when an Turning Point Therapeutics, Inc. insider buys or sells TPTX shares.

Notify only if

News

Receive news related to Turning Point Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TPTX